
Dr. Catherine Toomer discusses GLP-1 dosing strategies and their impact on metabolic disease and obesity care.
In this episode of The GLP-1 Podcast Show, I speak with Dr. Catherine Toomer, founder of Total Weight Care Institute and a family medicine physician specializing in metabolic disease. The discussion examines long-term clinical experience using GLP-1 therapies, including dosing strategies, metabolic regulation, and patient-centered obesity care. She also explores insulin resistance, brain signaling, and emerging therapeutic applications. Listen now on all major platforms! “Appetite regulation is strongly influenced by brain signaling pathways, and correcting metabolic signaling often changes hunger perception and eating behavior without relying on willpower alone.” Meet the guest: Dr. Catherine Toomer https://www.linkedin.com/in/drtoomer/ is a family medicine physician and founder of Total Weight Care Institute, with more than fifteen years of clinical experience using GLP-1 therapies to address metabolic disease and obesity. Her work focuses on correcting metabolic dysregulation through evidence-based medical strategies and personalized care. What you will learn: (00:00) Highlight (00:31) Introduction (01:52) Metabolic disease drivers (05:33) Personalized dosing strategy (07:17)…
Host: Wisenetix
Guest: Dr. Catherine Toomer
Organizations: Total Weight Care Institute
Explore listener stats, chart rankings, contacts and more on the The GLP-1 Podcast Show podcast page.